In non-diabetic patients, apoB—but not LDL-C—corresponded positively with dysfunctional white adipose tissue and delayed clearance of fat, hyperinsulinemia, insulin resistance, and activation of the IL-1β system, all of which are known risk factors for type 2 diabetes [168,177]. Here, APOB is linked to type 2 diabetes mellitus.